As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...

It has been studied extensively as a therapeutic target for cancer treatment, and several types of anti-mortalin molecules have ... and toxicity of mortalin-targeting strategies must be assessed.

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell.

Glioblastoma remains one of the most stubbornly difficult forms of cancer to treat ... WEE1 may also be an important target for cancers with mutations that cause DNA replication stress.

Cancer remains the second leading cause of death in the US, accounting for 25% of all deaths nationwide. Immunotherapy techniques bolster the immune cells’ ability to target malignant cancer cells and ...

UW Health's Dr. Jeff Pothof discusses a new study that shows a person's lifetime cancer risk may be set before birth. He also ...

Researchers have developed a computer model to help scientists identify tumor-fighting immune cells in patients with lung cancer treated with immune checkpoint inhibitors.

The Damon Runyon Cancer Research Foundation’s innovation grants support high-risk, high reward ideas in cancer research.

Two separate research teams have found ways to create short chains of amino acids, termed peptides, for the purpose of ...